Nexalin Technology- Warrants (15/09/2025) EBIT

The latest EBIT for NXLIW is $-9M as of June 2026. That compares with $-9M in the prior-year period — down 0.4% year over year. That is below the sector sector average of $-6.4M. Investors often review this figure alongside Nexalin Technology- Warrants (15/09/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NXLIW's EBIT moved from $-9M to $-9M — a 0.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nexalin Technology- Warrants (15/09/2025)'s operating scale or balance-sheet position.

Against its sector companies, NXLIW currently prints $-9M for EBIT, while the sector average sits near $-6.4M. That is roughly 41.3% below the sector mean. Large gaps often invite a closer look at Nexalin Technology- Warrants (15/09/2025)'s growth, margins, and balance sheet.

A EBIT figure of $-9M for NXLIW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-6.4M. Explore the charts below for those layers of context.

After noting NXLIW's EBIT ($-9M), review year-over-year change from $-9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.